D Funding

LONDON—Government spending on research is becoming a major issue in Britain's upcoming elections, with the major parties staking out their positions. Campaigning is not officially underway, but the election is expected to take place by early autumn. There is a growing split between the Conservative administration of Margaret Thatcher, which argues that state expenditure on research is about right, and opponents who believe more cash is needed to strengthen basic research and stem the trans

Written byJon Turney
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Campaigning is not officially underway, but the election is expected to take place by early autumn. There is a growing split between the Conservative administration of Margaret Thatcher, which argues that state expenditure on research is about right, and opponents who believe more cash is needed to strengthen basic research and stem the trans-Atlantic brain drain.

The opposition Labour Party has set forth the most comprehensive platform. Its proposals include a $4.8 billion increase in annual spending on industrial R&D, funded partly through taxes on corporate profits; cuts in defense R&D; and an increase in research funds funnelled through the five Research Councils and British universities (from $1.8 billion to $2.4 billion). Jeremy Bray, the party's spokesman on science and technology, has also said that Labour would increase spending on academic research by one-third within four years of taking office.

The plan was published in a week when the Government ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies